Abstract
Objectives
It is vital to rapid diagnosis and to determine the intensive care unit (ICU) requirement early to reduce the mortality rate in Fournier gangrene (FG) patients. Cell population data (CPD) are the parameters obtained from complete blood count (CBC) analysis and related to the activation of different leukocyte subgroups. The study aimed to find reliable markers to diagnose and determine the ICU requirement using CPD.
Methods
We included 24 patients and 22 healthy controls in the study. CBC analyses were performed by using a Sysmex XN-9000 series hematology analyzer. ROC analyses and group comparisons were performed to evaluate the diagnostic accuracy and prognostic value of CPD parameters in ICU requirements.
Results
Statistically significant differences were observed in terms of some CPD values of lymphocytes, neutrophils, and monocytes in patients compared to healthy controls. Neutrophile-Y or reactivity index (Ne-Y or RI) (p=0.004), neutrophile-X or granularity index (Ne-X or GI) (p=0.009), monocyte-X (Mo-X) (p<0.001), and lymphocyte-WY (Ly-WY) (p<0.001) were higher in patients than controls. Ne-Y (RI) (p=0.012), Mo-X (p=0.001), Mo-Y (p=0.022), and Ne-WY (p=0.025) levels were higher in ICU patients than in non-ICU patients.
Conclusions
The severity of FG disease can be determined using CPD data. Ne-Y (RI) serves as a novel and reliable biomarker for determining disease severity. In addition, the neutrophile-lymphocyte ratio can be used to rule out FG, especially in combination with other well-known clinical and diagnostic parameters.
Introduction
Fournier Gangrene (FG) is a rare but serious condition that involves the rapid spread of a bacterial infection in the genital and perianal regions. It is a necrotizing fasciitis that affects the subcutaneous tissue, fascia, and muscle in the genital area. FG can progress rapidly, leading to sepsis, multi-organ failure, and death [1]. Several predisposing factors, including diabetes, advanced age, smoking, chronic alcoholism, peripheral vascular disease, congestive heart failure, hypertension, obesity, renal failure, coagulopathy, liver failure, local trauma, paraphimosis, urinary extravasation, and perianal abscess, have been associated with FG [2]. The causative agent of the infection is generally facultative bacteria such as Escherichia coli, Klebsiella spp., and Enterococcus spp. or anaerobic bacteria such as Bacteroides sp. [3].
Because of the high mortality rate, urgent urological intervention should be performed. Delayed treatment can lead to septic shock, multi-organ failure, and death. The most important determinants affecting mortality are early diagnosis, extensive surgical debridement, and using broad-spectrum antibiotics [4]. However, patients may need intensive care even if diagnosed early or treated aggressively. The Fournier Gangrene Scoring Index (FGSI) and Uludağ Fournier Gangrene Scoring Index (UFGSI) are used in determining the severity and predicting mortality of cases with FG [5, 6]. These scores are a numerical scoring system that considers various clinical and laboratory parameters to determine the extent and severity of the infection. While they are valuable tools for assessing severity, they have some limitations, such as limited validation and assessment of wound extent and comorbidities. Besides, some parameters used in these indexes, such as heart and respiratory rates, can be subjective and influenced by various factors such as pain, anxiety, or medications.
Complete blood count (CBC) is a commonly ordered blood test that provides information about various blood components, including erythrocytes, leukocytes, and platelets. One of the components of CBC is the measurement of various parameters of white blood cells, also known as leukocytes. Leukocytes are an essential part of the immune system, and their blood levels and population parameters can provide important clinical information. The new generation Sysmex XN-9000 analyzer can perform an extended leukocyte analysis known as cell population data (CPD) parameters. The leukocyte scattergrams are used to calculate CPD parameters based on lateral light scatter, forward light scattered light, and fluorescence light intensity for each leukocyte subgroup. These parameters indicate granular structures, reactivity, DNA and RNA content, metabolic activity, and size of leukocytes.
During acute bacterial infections, the bone marrow exhibits a response characterized by an elevation in the circulating levels of neutrophils and immature granulocytes. However, beyond this response, the significance of morphological and metabolic activity alterations within leukocyte subgroups among FG patients remains unclear. The aim of this study was to investigate the CPD-based biomarkers for the diagnosis and severity assessment of FG, distinguishing patients from healthy controls and predicting disease progression.
Materials and methods
Study population and protocol
We thoroughly reviewed the medical records of 24 patients diagnosed with FG who received treatment at our institution from August 2020 to May 2021. The diagnosis of FG was based on physical examination, laboratory results, and imaging methods conducted upon admission. Exclusion criteria were applied to patients without any signs of necrosis or soft tissue spread. Physical examination, presenting signs and symptoms, medical history, comorbidities, demographic characteristics, skin involvement, laboratory results, antibiotic treatment, extent of surgical interventions, need for intensive care, and disease outcomes were recorded. Primary infection sources of the patients were recorded as urogenital or anorectal. Additional diseases, such as diabetes mellitus and urinary tract infections, were questioned. FGSI, UFGSI, and Quick SOFA scores were calculated by evaluating clinical findings and laboratory data. The FGSI assesses a number of parameters, including temperature, heart rate, respiratory rate, serum sodium, potassium, creatinine, and hematocrit. Each of these parameters is given a score, and the sum of these scores provides an overall severity index that helps clinicians estimate the severity and prognosis of the condition. The UFGSI includes additional parameters such as age, white blood cell count, glucose level, and C-reactive protein level. The UFGSI is designed to enhance the precision of severity assessment and prognosis prediction in patients with Fournier’ gangrene. FGSI and UFGSI values at admission are predicted to be higher in non-survivors than in survivors.
Lesions limited to the urogenital and anorectal regions at the time of admission were considered a localized disease, and lesions that had progressed to the pelvic region or exceeded the boundaries of the pelvis were considered an extended disease. Surgical procedures such as orchiectomy, cystostomy or colostomy performed during follow-up were recorded. Patients were statistically evaluated according to their hospitalization status in the ward or intensive care unit. In addition to the patients, a control group of healthy subjects (n=22) was included in the study. The control group was selected from people who did not have a known acute or chronic infectious disease and did not use anti-inflammatory or immunosuppressant drugs. However, two healthy controls were excluded from the study due to eosinophilia, and the remaining 22 healthy individuals were considered the control group. The research related to human use has complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration and has been approved by the authors’ Institutional Review Board (Ethical Committee of Sivas Cumhuriyet University approval number 2020-07/20). Due to the retrospective design of the study, informed consent was not obtained from the participants.
Concepts of cell population data
The CBC and CPD parameters were obtained with a Sysmex-XN 9000 (Sysmex, Inc. Kobe Japan) analyzer using fluorescence flow cytometry technology. Leukocyte and subgroup count, expanded inflammation parameters (neutrophil reactivity index (RI) and granularity index (GI), antibody-synthesizing (AS) lymphocytes and reactive (RE) lymphocytes counts and percentages), and cell population indexes (X, Y, Z) and distributions widths (WX, WY, WZ) were evaluated. An increase in the lateral scatter light value (SSC or X) indicates an increase in granular structures of the cell population and has been defined as the granularity index specifically for neutrophils (Ne-GI or Ne-X). Higher fluorescent light intensity (SFL or Y) is associated with increased DNA and RNA content and metabolic activity of the cell population. It is also known as neutrophil reactivity (Ne-RI or Ne-Y). Increases in both neutrophil reactivity (Ne-RI or Ne-Y) and granularity (Ne-GI or Ne-X) indexes suggest that cells are active. Increased forward light scatter value (FSC or Z) correlates with larger cell size. Low WX, WY, and WZ values indicate that the population is homogeneous and similar in terms of granularity, activity, and size, respectively. In contrast, high values show that the cell distribution is heterogeneous and different. The count and percentages of reactive lymphocytes (RE-Ly) and antigen-synthesizing lymphocytes (AS-Ly), which are among the extended inflammation parameters, are calculated from the population of lymphocytes with increased fluorescence light intensity. These lymphocyte indexes can be used to evaluate cell-mediated innate and antibody-responsive adaptive immunity. Figure 1 provides an illustration of these values.

Scattergrams of white cell differential (WDF) channel for peripheral blood samples from a healthy person and a Fournier gangrene patient performed by Sysmex-XN 9000. Leukocyte subgroups are shown in different colors as follows: eosinophils (red), lymphocytes (pink), monocytes (green), and neutrophils (light blue). SFL, fluorescence light intensity; SSC, side scatter; Ne-GI or Ne-X, lateral scattered light intensity of neutrophils; Ne-RI or Ne-Y, fluorescent light intensity of neutrophils; Ne-WX, lateral scattered light distribution width of neutrophils; Ly-WY, fluorescent light distribution width of lymphocytes.
Statistical analysis
Data obtained in the study were analyzed statistically using SPSS software (IBM Corp., SPSS Statistics for Windows, Version 23.0. Armonk, NY, USA) and GraphPad Prism version 8.3.0 (San Diego, CA, USA, www.graphpad.com) used for data visualization. Conformity of the data to normal distribution was assessed using the Shapiro-Wilk test. The independent group t-test was used for normally distributed data, and the Mann-Whitney U test for non-normally distributed data. Categorical data were evaluated with the Chi-square or Fisher’s Exact tests. ROC analysis was performed to find the predictive power and cut-off values for intensive care needs, and the Area Under the Curve (AUC) values were compared. The error level was taken as 0.05.
Results
The mean age of the patients was 59 ± 16 years, and only one (4 %) was female. Diabetes mellitus was present in 10 patients (42 %), and urinary tract infections were diagnosed in 15 patients (63 %). Orchiectomy (for male patients) was performed in 8 (35 %), colostomy in 3 (13 %), and cystostomy in 3 (13 %). The primary infection was urogenital in 16 (67 %) patients and anorectal region in 8 (33 %). The extended disease was determined in 9 (38 %) patients. The mean FGSI and UFGSI values of the patients on admission were 3.5 ± 2.7 and 6.2 ± 3.9, respectively. A high level of positive correlation was found between the two indexes (Pearson correlation coefficient r=0.897, p<0.001). For quick SOFA value and length of stay (day), the median and quartiles were found to be 1 (0–1) and 18 (9–32), respectively. Seven (29 %) patients required intensive care, and mortality developed in two (8 %). The demographic and descriptive information of the patients and group comparisons are shown in Table 1.
The demographic and descriptive information of Fournier gangrene patients according to intensive care unit requirement.
Variables | Intensive care unit requirement of patients | p-Value | OR | 95 % CI | |
---|---|---|---|---|---|
No (n=17) | Yes (n=7) | ||||
Age, years | 58 ± 18 | 61 ± 10 | 0.653 | – | |
Sex (female/male), n | 0/17 | 1/6 | 0.292 | – | |
Physical examination findings | |||||
Body temperature, ˚C | 36.8 (36.6–37.9) | 36.9 (36.5–38.2) | 0.951 | – | |
Pulse, min | 90 ± 15 | 101 ± 25 | 0.339 | – | |
Blood pressure, mmHg | 120 (115–130) | 110 (100–120) | 0.040 | – | |
Respiratory rate, min | 22 (20–24) | 20 (20–26) | 0.951 | – | |
Length of stay, days | 18 (8–27) | 36 (10–37) | 0.055 | – | |
Diabetes mellitus, n | 9 | 1 | 0.172 | – | |
Urinary tract infection, n | 14 | 1 | 0.004 | 0.036 | 0.003–0.417 |
Primary infection (urogenital/anorectal), n | 14/3 | 2/5 | 0.021 | 12 | 1.5–92 |
Extended disease, n | 3 | 6 | 0.004 | 28 | 2.4–327 |
Surgical interventions | |||||
Orchiectomy, n | 6 | 2 | 1.000 | – | |
Colostomy, n | 0 | 3 | 0.017 | 27 | 1.2–628 |
Cystostomy, n | 2 | 1 | 1.000 | – | |
Severity scores | |||||
FGSI | 3 (0–4) | 7 (4–8) | 0.002 | 3.04 | 1.16–7.94 |
UFGSI | 4 (2–6) | 10 (10–12) | 0.001 | 1.96 | 1.2–3.19 |
qSOFA | 0 (0–1) | 1 (1–2) | 0.003 | – |
-
Data are given as mean and standard deviation or median and quartiles according to distribution characteristics. Statistical analyses were performed with the chi-square test for categorical data and independent samples t-test or Mann-Whitney U test according to the normality assumption for continuous data. Bold values indicate p<0.05. CI, confidence intervals; FGSI, Fournier Gangrene Scoring Index; OR, odds ratio; qSOFA, quick sequential organ failure assessment; UFGSI, Uludağ Fournier Gangrene Scoring Index.
The patients were separated into two groups as those who needed intensive care (n=7) and those who did not (n=17). There was no difference between these two groups in terms of age and gender. The frequency of diabetes mellitus and urinary tract infections was low in intensive care patients, with a significant difference determined only for urinary tract infections (p=0.004). The odds ratio for urinary tract infection frequency in these patients was found to be 0.036 (p=0.008). In intensive care patients, the colostomy rate was 27-fold higher (OR, p=0.039). No significant difference was found in terms of orchiectomy and cystostomy procedures. Anorectal primary infection was 12 times more common (OR, p=0.019) in intensive care patients. The rate of extended disease involving or exceeding the pelvic region was 28-fold (OR, p=0.008) higher in intensive care patients. There was no difference in body temperature, pulse, and respiratory rate, but systolic arterial pressure was significantly lower in intensive care patients (p=0.040). The FGSI (p=0.002), UFGSI (p=0.001), and qSOFA (0.003) scores on admission were higher in intensive care patients. There was no difference in terms of length of hospital stay.
Statistically significant differences were observed in terms of some CPD values of lymphocytes, neutrophiles, and monocytes in patients compared to healthy controls. Neutrophile-Y or reactivity index (Ne-Y or RI) (p=0.004), neutrophile-X or granularity index (Ne-X or GI) (p=0.009), monocyte-X (Mo-X) (p<0.001), and lymphocyte-WY (Ly-WY) (p<0.001) were higher in patients than controls. Ne-Y (RI) (p=0.012), Mo-X (p=0.001), Mo-Y (p=0.022), and Ne-WY (p=0.025) levels were higher in ICU patients than in non-ICU patients (Table 2).
Comparison of Fournier gangrene patients with the control group or according to their intensive care unit requirement.
Variables | Control group (n=22) |
Patient group (n=24) |
p-Value | Intensive care unit requirement of patients | p-Value | |
---|---|---|---|---|---|---|
No (n=17) | Yes (n=7) | |||||
WBC#, 109/L | 7.25 ± 1.1 | 13.4 ± 5.4 | <0.001 | 13.8 ± 5.9 | 12.5 ± 4.0 | 0.631 |
Ne#, 109/L | 4.28 ± 1.1 | 10.7 ± 5.2 | <0.001 | 10.9 ± 5.7 | 10.8 ± 3.4 | 0.97 |
Ly#, 109/L | 2.19 ± 0.37 | 1.52 ± 0.72 | <0.001 | 1.73 ± 0.69 | 1.03 ± 0.55 | 0.025 |
Mo#, 109/L | 0.59 ± 0.11 | 0.89 ± 0.44 | 0.003 | 0.91 (0.66–1.08) | 0.57 (0.46–0.80) | 0.057 |
Ne% | 58.6 ± 6.6 | 78.6 ± 13.4 | <0.001 | 74.9 ± 14.0 | 87.6 ± 5.1 | 0.031 |
Ly% | 30.7 ± 5.6 | 11.9 ± 7.2 | <0.001 | 13.8 ± 7.5 | 7.6 ± 4.1 | 0.054 |
Mo% | 8.3 ± 1.7 | 6.5 ± 2.3 | 0.006 | 7.5 ± 1.9 | 4.2 ± 1.4 | <0.001 |
IG#, 109/L | 0.02 (0.02–0.03) | 0.09 (0.05–0.43) | <0.001 | 0.08 (0.05–0.36) | 0.26 (0.06–1.07) | 0.293 |
IG% | 0.3 (0.3–0.4) | 0.8 (0.5–2.6) | <0.001 | 0.8 (0.5–2.2) | 1.8 (0.5–5.5) | 0.419 |
Ne-X or GI | 153 ± 4.0 | 156 ± 4.5 | 0.009 | 155 ± 3.5 | 159 ± 6.1 | 0.075 |
Ne-Y or RI | 47.0 ± 2.5 | 52.2 ± 7.5 | 0.004 | 49.0 ± 3.7 | 61.4 ± 8.1 | 0.012 |
Ne-Z | 91.1 ± 3.6 | 88.2 ± 5.6 | 0.047 | 88.9 ± 5.2 | 86.3 ± 6.6 | 0.362 |
Ly-X | 79.8 ± 2.0 | 81.2 ± 3.4 | 0.11 | 80.8 ± 2.9 | 82.2 ± 4.8 | 0.426 |
Ly-Y | 68.2 ± 2.6 | 66.7 ± 4.9 | 0.202 | 66.8 ± 5.3 | 66.5 ± 3.9 | 0.899 |
Ly-Z | 59.3 ± 1.3 | 59.6 ± 2.2 | 0.663 | 59.4 ± 2.3 | 60.0 ± 2.0 | 0.572 |
Mo-X | 119 ± 1.7 | 123 ± 3.6 | <0.001 | 122 ± 2.2 | 127 ± 4.2 | 0.001 |
Mo-Y | 110 ± 5.8 | 109 ± 10.0 | 0.691 | 107 ± 7.9 | 117 ± 12.1 | 0.022 |
Mo-Z | 66.7 ± 3.5 | 65.6 ± 3.9 | 0.314 | 65.1 ± 3.1 | 67.0 ± 5.7 | 0.486 |
Ne-WX | 302 ± 14.4 | 319 ± 15.3 | 0.001 | 316 ± 14.7 | 327 ± 15.2 | 0.132 |
Ne-WY | 601 (576–618) | 681 (640–816) | <0.001 | 669 (628–758) | 861 (722–990) | 0.025 |
Ne-WZ | 677 (622–706) | 719 (685–800) | 0.006 | 719 (693–749) | 723 (665–835) | 0.944 |
Ly-WX | 454 (438–503) | 452 (410–553) | 0.847 | 450 (412–551) | 485 (396–750) | 0.624 |
Ly-WY | 832 ± 58.8 | 936 ± 107 | <0.001 | 914 ± 105 | 1,014 ± 84 | 0.064 |
Ly-WZ | 549 ± 66.2 | 550 ± 97.3 | 0.947 | 546 ± 83.0 | 562 ± 139 | 0.734 |
Mo-WX | 257 ± 22.8 | 282 ± 27.3 | 0.002 | 283 ± 24.3 | 280 ± 36.9 | 0.807 |
Mo-WY | 677 ± 83.1 | 730 ± 72.2 | 0.031 | 733 ± 66.7 | 720 ± 91.6 | 0.713 |
Mo-WZ | 614 ± 75.1 | 652 ± 107 | 0.177 | 663 ± 101 | 622 ± 126 | 0.437 |
AS-Ly#, 109/L | 0 (0–0) | 0 (0–0.003) | 0.07 | 0 (0–0) | 0 (0–0.02) | 0.547 |
RE-Ly#, 109/L | 0.07 ± 0.03 | 0.07 ± 0.04 | 0.669 | 0.06 ± 0.03 | 0.09 ± 0.05 | 0.175 |
AS-Ly% | 0 (0–0) | 0 (0–0.03) | 0.073 | 0 (0–0) | 0 (0–0.2) | 0.514 |
RE-Ly% | 0.91 ± 0.43 | 0.56 ± 0.33 | 0.005 | 0.53 ± 0.28 | 0.63 ± 0.0.46 | 0.635 |
NLR | 1.97 (1.57–2.27) | 6.91 (4.8–12.1) | <0.001 | 5.9 (3.66–10.2) | 10.5 (6.8–16.9) | 0.098 |
SII | 481 ± 159 | 2,422 ± 1,588 | <0.001 | 2,069 ± 1,463 | 3,303 ± 1,671 | 0.109 |
-
Data are given as mean and standard deviation or median and quartiles according to distribution characteristics. Statistical analyses for continuous data were performed with independent samples t-test or Mann-Whitney U test according to the normality assumption. Bold values indicate p<0.05. AS-Ly, antibody-synthesizing lymphocytes; IG; immature granulocytes; Ly, lymphocytes; Mo, monocytes; Ne, neutrophils; NLR, neutrophil-lymphocyte ratio; RE-Ly, reactive lymphocytes; SII, systemic inflammation index; WBC, white blood cells; X, lateral scatter light intensity; Y, fluorescence light intensity; Z, forward scatter light intensity; WX, WY or WZ, distribution width for X, Y or Z value.
Table 3 shows ROC analysis results for predicting the diagnosis of FG. AUC values above 0.9 for Neutrophile-Lymphocyte Ratio (NLR), Ly%, immature granulocyte count (IG#), Ne#, Ne%, and Ne-WY. All parameters had 100 % negative predictive values. ROC analyses were also performed to evaluate the power of the tests to predict the need for intensive care (Table 4 and Figure 2). Ne-Y (RI) had the highest AUC value compared to all other CPD and scoring indexes. Sensitivity and specificity for intensive care needs were calculated as 71.4 % and 100 % for FGSI at a cut-off value >5 and 100 % and 80 % for Ne-RI at a cut-off value >52, respectively. It was noteworthy that the negative predictive value for Ne-RI and positive predictive value for FGSI was 100 %.
ROC analysis results for predicting the diagnosis of Fournier gangrene.
Variables | Cut-off value | AUC | SEN | SPE | LR (+) | LR (−) | PPV | NPV |
---|---|---|---|---|---|---|---|---|
WBC#, 109/L | >9.53 | 0.872a | 0.70 (0.47–0.87) | 1.0 (0.85–1.0) | 0.30 (0.16–0.56) | 1.0 | 1.0 (1.0–1.0) | |
Ne#, 109/L | >6.6 | 0.911a | 0.74 (0.52–0.90) | 1.0 (0.85–1.0) | 0.26 (0.13–0.52) | 1.0 | 1.0 (1.0–1.0) | |
Ly#, 109/L | ≤1.69 | 0.781a | 0.67 (0.45–0.84) | 0.96 (0.77–1.0) | 14.67 (2.12–102) | 0.35 (0.20–0.62) | 0.0002 | 1.0 (1.0–1.0) |
Mo#, 109/L | >0.74 | 0.741a | 0.58 (0.37–0.78) | 1.0 (0.85–1.0) | 0.42 (0.26–0.67) | 1.0 | 1.0 (1.0–1.0) | |
Ne% | >63.1 | 0.922a | 0.92 (0.73–0.99) | 0.86 (0.65–0.97) | 6.72 (2.33–19.4) | 0.10 (0.03–0.37) | 0.0001 | 1.0 (1.0–1.0) |
Ly% | ≤20.8 | 0.966a | 0.87 (0.64–0.97) | 1.0 (0.85–1.0) | 0.13 (0.05–0.37) | 1.0 | 1.0 (1.0–1.0) | |
Mo% | ≤7.9 | 0.745a | 0.83 (0.63–0.95) | 0.64 (0.41–0.83) | 2.29 (1.28–4.10) | 0.26 (0.10–0.68) | 0.00004 | 1.0 (1.0–1.0) |
IG#, 109/L | >0.03 | 0.962a | 0.91 (0.72–0.99) | 1.0 (0.85–1.0) | 0.09 (0.02–0.33) | 1.0 | 1.0 (1.0–1.0) | |
IG% | >0.4 | 0.885a | 0.78 (0.56–0.93) | 1.0 (0.85–1.0) | 0.22 (0.10–0.47) | 1.0 | 1.0 (1.0–1.0) | |
Ne-X or GI | >155.4 | 0.717a | 0.70 (0.47–0.87) | 0.82 (0.60–0.95) | 3.83 (1.51–9.67) | 0.37 (0.19–0.71) | 0.00006 | 1.0 (1.0–1.0) |
Ne-Y or RI | >50.5 | 0.742a | 0.48 (0.27–0.69) | 0.95 (0.77–1.0) | 10.5 (1.48–74.8) | 0.55 (0.37–0.82) | 0.0002 | 1.0 (1.0–1.0) |
Ne-Z | ≤87.6 | 0.683a | 0.65 (0.43–0.84) | 0.82 (0.60–0.95) | 3.59 (1.41–9.14) | 0.43 (0.23–0.77) | 0.00006 | 1.0 (1.0–1.0) |
Mo-X | >120.6 | 0.897a | 0.78 (0.56–0.93) | 0.91 (0.71–0.99) | 8.61 (2.26–32.8) | 0.24 (0.11–0.53) | 0.0001 | 1.0 (1.0–1.0) |
Ne-WX | >303 | 0.799a | 0.86 (0.65–0.97) | 0.64 (0.41–0.83) | 2.37 (1.33–4.23) | 0.21 (0.07–0.64) | 0.00004 | 1.0 (1.0–1.0) |
Ne-WY | >614 | 0.911a | 0.91 (0.72–0.99) | 0.77 (0.55–0.92) | 4.02 (1.84–8.77) | 0.11 (0.03–0.43) | 0.00006 | 1.0 (1.0–1.0) |
Ne-WZ | >690 | 0.737a | 0.74 (0.52–0.90) | 0.68 (0.45–0.86) | 2.32 (1.20–4.49) | 0.38 (0.18–0.81) | 0.00004 | 1.0 (1.0–1.0) |
Ly-WY | >884 | 0.786a | 0.68 (0.45–0.86) | 0.86 (0.65–0.97) | 5.0 (1.68–14.9) | 0.37 (0.20–0.69) | 0.00008 | 1.0 (1.0–1.0) |
Mo-WX | >271 | 0.749a | 0.61 (0.39–0.80) | 0.77 (0.55–0.92) | 2.68 (1.16–6.19) | 0.51 (0.29–0.88) | 0.00004 | 1.0 (1.0–1.0) |
Mo-WY | >694 | 0.675a | 0.63 (0.41–0.83) | 0.68 (0.45–0.86) | 2.0 (1.00–3.98) | 0.53 (0.29–0.99) | 0.00003 | 1.0 (1.0–1.0) |
RE-Ly% | ≤0.5 | 0.742a | 0.57 (0.34–0.78) | 0.91 (0.71–0.99) | 6.29 (1.59–24.8) | 0.47 (0.28–0.79) | 0.0001 | 1.0 (1.0–1.0) |
NLR | >2.96 | 0.967a | 0.95 (0.77–1.0) | 0.91 (0.71–0.99) | 10.5 (2.79–39.5) | 0.05 (0.01–0.34) | 0.0002 | 1.0 (1.0–1.0) |
SII | >822 | 0.890a | 0.86 (0.64–0.97) | 1.0 (0.85–1.0) | 0.14 (0.05–0.41) | 1.0 | 1.0 (1.0–1.0) |
-
ap<0.05. AUC, area under the ROC curve; SEN, sensitivity; SPE, specificity; LR (+), positive likelihood ratio; LR (−), negative likelihood ratio; PPV, positive predictive value; NPV, negative predictive value; #, cell count; IG; immature granulocytes; Ly, lymphocytes; Mo, monocytes; Ne, neutrophils; NLR, neutrophil-lymphocyte ratio; RE-Ly, reactive lymphocytes; SII, systemic inflammation index; WBC, white blood cells; X, lateral scatter light intensity; Y, fluorescence light intensity; Z, forward scatter light intensity; WX, WY or WZ, distribution width for X, Y or Z value.
ROC analysis results for predicting the intensive care requirements of patients.
Variables | Cut-off value | AUC | SEN | SPE | LR (+) | LR (−) | PPV | NPV |
---|---|---|---|---|---|---|---|---|
Ne-Y or RI | >52 | 0.96a | 1.0 (0.54–1.0) | 0.88 (0.64–0.99) | 8.5 (2.31–31.25) | 0 | 0.78 (0.49–0.93) | 1.0 |
UFGSI | >7 | 0.94a | 0.86 (0.42–1.0) | 0.94 (0.71–1.0) | 14.57 (2.12–99.9) | 0.15 (0.03–0.94) | 0.86 (0.47–0.98) | 0.94 (0.72–0.99) |
Mo% | ≤4.5 | 0.924a | 0.86 (0.42–1.0) | 0.94 (0.71–1.0) | 14.57 (2.12–99.9) | 0.15 (0.03–0.94) | 0.86 (0.47–0.98) | 0.94 (0.72–0.99) |
FGSI | >5 | 0.903a | 0.71 (0.29–0.96) | 1.0 (0.81–1.0) | 0.29 (0.09–0.92) | 1.0 | 0.90 (0.73–0.97) | |
Mo-X | >124.2 | 0.873a | 0.67 (0.22–0.96) | 0.94 (0.71–1.0) | 11.33 (1.56–82.4) | 0.35 (0.11–1.1) | 0.82 (0.39–0.97) | 0.87 (0.69–0.96) |
Ne% | >86.3 | 0.828a | 0.71 (0.29–0.96) | 0.88 (0.64–0.99) | 6.07 (1.52–24.2) | 0.32 (0.10–1.06) | 0.71 (0.39–0.91) | 0.88 (0.70–0.96) |
Ne-WY | >717 | 0.814a | 0.83 (0.36–1.0) | 0.71 (0.44–0.90) | 2.83 (1.25–6.43) | 0.24 (0.04–1.45) | 0.54 (0.34–0.73) | 0.91 (0.63–0.98) |
Ly# (109/L) | ≤1.05 | 0.807a | 0.71 (0.29–0.96) | 0.88 (0.64–0.99) | 6.07 (1.52–24.2) | 0.32 (0.10–1.06) | 0.71 (0.39–0.91) | 0.88 (0.70–0.96) |
Mo-Y | >114.1 | 0.765 | 0.83 (0.36–1.0) | 0.82 (0.57–0.96) | 4.72 (1.59–14.0) | 0.20 (0.03–1.23) | 0.66 (0.40–0.85) | 0.92 (0.66–0.99) |
-
ap<0.05. AUC, area under the ROC curve; SEN, sensitivity; SPE, specificity; LR (+), positive likelihood ratio; LR (−), negative likelihood ratio; PPV, positive predictive value; NPV, negative predictive value; FGSI, Fournier Gangrene Scoring Index; Ly#, lymphocytes count; Mo-X, lateral scattered light intensity of monocytes; Mo-Y, fluorescent light intensity of monocytes; Ne-Y or RI, fluorescent light intensity of neutrophils; Ne-WY, fluorescent light distribution width of neutrophils; UFGSI, Uludağ Fournier Gangrene Scoring Index.

ROC analysis plot and AUC values for estimation of the need for intensive care unit. FGSI, Fournier Gangrene Scoring Index; ly#, lymphocytes count; Mo-X, lateral scattered light intensity of monocytes; Mo-Y, fluorescent light intensity of monocytes; Ne-RI or Ne-Y, fluorescent light intensity of neutrophils; Ne-WY, fluorescent light distribution width of neutrophils; UFGSI, uludağ Fournier Gangrene Scoring Index.
Discussion
Fournier gangrene is characterized by fulminant necrotizing fasciitis in the perineum or genital area. Immunosuppression, diabetes mellitus, alcoholism, acquired immunodeficiency, trauma, and genitourinary infections constitute predisposing factors for FG [7]. The disease can develop in three ways: lower urinary tract infections, infections in and around the rectum, and infections caused by bacteria on the skin after injury. Previous studies have shown that it causes mortality, although at different rates. FG is associated with poor health conditions in low socioeconomic groups, diabetes mellitus, and alcoholic liver disease, and diabetes is recognized as the most important medical condition [8]. The FGSI and UFGSI are classification systems used to evaluate the severity and course of the disease [9]. Since FG is an infectious disease, it is known that it causes changes in blood count parameters, and therefore several scoring systems utilizing these changes are used in disease prognosis [10]. One of the objectives of this study is to enhance prognosis prediction by incorporating leukocyte population indices alongside existing scoring systems.
This study presents the data of 24 FG patients, comprising 1 female and 23 males, who were followed up prospectively over the past year. Among these patients, seven (29 %) required intensive care units, and two (8 %) did not survive. Sepsis and multiple organ failure were the main determinants of intensive care need and mortality. Without the appropriate treatment, the mortality risk is high in this serious infection. However, we believe that using broad-spectrum antibiotics, enhancements in intensive care facilities, and early surgical debridement have significantly improved overall survival. Similar to the rates reported in the literature, 42 % of the patients had diabetes mellitus. However, no statistically significant correlation was observed between diabetes mellitus and the need for intensive care or death rates. Cystostomy was performed in three patients due to the spread of gangrene to the penis and urethra. Although FG typically leaves the testicles intact, the severity of infection and repetitive debridement can cause irreversible damage due to circulatory disturbance. Therefore, orchiectomy was performed in eight males to optimize patient outcomes and minimize complications after evaluating the patient’s general condition and the severity of the infection. As a result of anal sphincter involvement, three patients required the colostomy. In five of the seven patients who required intensive care, the source of infection was anorectal, and in only two of these cases was urogenital.
A relationship has been found between extended disease and the patient’s need for intensive care. While extended disease involving and exceeding the pelvic region was present in three of 17 patients who did not need intensive care, it was present in six of seven patients who needed intensive care. As a result, it is evident that the severity of the clinical condition is related to the extent of the disease.
It can be stated that the UFGSI score is a more valuable predictor than FGSI according to the ROC curve made in terms of predicting the requirement for intensive care. Similar to these scoring systems, the percentage of monocytes and neutrophils and lymphocytes count parameters that are frequently used in daily practice also provide valuable information.
There was a significant difference between the patient and healthy group in respect of the NLR and systemic inflammation index (SII), but patients hospitalized in the ward and intensive care units did not differ significantly in terms of these indexes. Therefore, NLR and SII are not considered appropriate indicators for predicting intensive care admission and disease severity.
The FGSI, UFGSI, and qSOFA scores were found to be high in patients who needed intensive care and were correlated with each other. Roghmann et al. showed that FGSI and UFGSI are useful in determining mortality, and it was seen in the current study that the indexes could be used to indicate the intensive care unit requirements [9]. Doluoğlu et al. showed that high FGSI and Charlson Comorbidity Index scores can be associated with poor prognosis [11]. In that study, it was concluded that metabolic parameters and predisposing factors should be evaluated together to predict prognosis. Although the indexes have been shown to be effective in predicting prognosis, the host factors and source of infection can also be considered important.
Extended hemogram parameters are used with increasing frequency in the diagnosis and prognosis of diseases. In a study by Demir et al. platelet count and NLR were found to be negatively associated with mortality [10]. In the literature review, no study was found showing the relationship between expanded hemogram parameters and FG. A comparison of the patient group and healthy controls found a significant increase in favor of the patient group in terms of leukocytes, monocytes, neutrophils, and immature granulocytes. It was observed that the neutrophil and monocyte population indexes were elevated in the group requiring intensive care unit.
Additional significant alterations were identified in the extended hemogram parameters of FG patients. Cell population data such as Ne-RI, Mo-X, Ne-WY, and Mo-Y provide valuable information about a patient’s need for intensive care unit admission and the severity of the clinical condition. The Ne-RI and Mo-Y parameters are obtained with fluorescent dyes that mark the nucleic acids of neutrophils and monocytes. These indexes are proportional to DNA/RNA content and reflect increases in cell reactivity. The data obtained in the study revealed that the Ne-RI value was increased in FG compared to the healthy subjects. Furthermore, it was observed to be notably higher in patients who needed intensive care compared to those who did not, and this value was determined with the highest performance in ROC analysis.
Another parameter indicative of neutrophil activity, Ne-GI, demonstrates an increase in granule contents. The Ne-GI was seen to be elevated in the patient group; however, it did not effectively predict the requirement for intensive care. Consistent with the findings of this study, Ustyantseva et al. showed that Ne-RI was higher in patients with sepsis compared to patients without sepsis and the control group, but Ne-GI did not differ between patients with and without sepsis [12].
It has also been shown that in addition to Ne-RI, the Mo-X value may be of clinical benefit in diagnosing and managing sepsis in intensive care patients [13]. In this study, it was observed that Mo-X and Ne-RI were significantly increased in patients with FG compared to healthy individuals, and these parameters can be used to predict the need for intensive care.
In a different study conducted with sepsis patients, increases were found in both Ne-RI and Ne-WY, which shows neutrophil activity and maturation heterogeneity [14]. It has also been stated that Ne-WY can be used to differentiate viral and bacterial diseases in the etiology of fever [15]. The data of the current study showed that Ne-WY could be used to predict the need for intensive care in cases with FG, in line with previous studies.
C-reactive protein (CRP) and procalcitonin represent primary acute-phase reactants widely employed in diagnosing bacterial infections. While their diagnostic efficacy in identifying sepsis is acknowledged, their utility as therapeutic indicators is constrained by their relatively prolonged kinetics of decline following treatment initiation. In contrast, as an indicator of metabolic activity heterogeneity, Ne-WY shows rapidly decreasing characteristics in patients recovering from the onset of sepsis [16]. Ne-WY is an interesting marker in the context of sepsis management as a more dynamic indicator of response to treatment compared to traditional acute-phase reactants and has the potential to overcome the weaknesses of acute phase markers at this stage. Therefore, using Ne-WY alone or in combination with CRP and procalcitonin can be particularly valuable in monitoring the efficacy of interventions and guiding decisions regarding the duration or intensity of treatment.
Peripheral blood smear evaluation is frequently used to detect banded neutrophils and immature granulocytes, such as toxic granulation and vacuolization, which is considered a left shift in leukocyte populations during infections. However, it is labor-intensive and time-consuming due to manual processes. Another limitation is that the evaluation is prone to errors due to inter-individual variation. Blood counting systems automate these processes, saving time and providing more objective and precise results. These devices analyze thousands of cells for size, granularity, and metabolic activity for each cell subgroup in the leukocyte population. The CPD parameters can be used in clinical practice as a rapid alternative to peripheral blood smear evaluation to detect bacterial and postsurgical infections [17].
One of the most significant limitations of our study, which investigates potential new markers for FG diagnosis and prognosis, is the necessity for careful interpretation of the results due to the small sample size. The relatively low incidence of FG limits the study’s statistical power when conducted at a single center. However, this challenge can be mitigated by performing multicenter studies to increase the sample size and enhance the robustness of the findings. Additionally, using intensive care unit patients without signs of infection or sepsis as the control group helps improve the comparisons. Our study did not follow changes in CPD parameters throughout the disease process. Future research should focus on these dynamics to provide further insights into disease prognosis. Lastly, it is important to note that these markers are currently investigational and not yet part of routine blood count reports.
Conclusions
The severity of FG disease can be determined using CDP data. Ne-Y (RI) serves as a novel and reliable biomarker for determining disease severity. Additionally, NLR can be used to rule out FG, especially in combination with other well-known clinical and diagnostic parameters. However, our findings should be interpreted with caution due to the small sample size. While these results provide important preliminary data, larger studies with more participants are necessary to confirm these findings and improve the generalizability and statistical power of the study.
-
Research ethics: The research related to human use has complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration and has been approved by the authors’ Institutional Review Board or equivalent committee (Ethical Committee of Sivas Cumhuriyet University approval number 2020-07/20).
-
Informed consent: Due to the retrospective design of the study, informed consent was not obtained from the participants.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: The raw data can be obtained on request from the corresponding author.
References
1. Norton, KS, Johnson, LW, Perry, T, Perry, KH, Sehon, JK, Zibari, GB. Management of Fournier’s gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Sur 2002;68:709–13. https://doi.org/10.1177/000313480206800810.Search in Google Scholar
2. Lin, TY, Cheng, IH, Ou, CH, Tsai, YS, Tong, YC, Cheng, HL, et al.. Incorporating simplified Fournier’s gangrene severity index with early surgical intervention can maximize survival in high-risk Fournier’s gangrene patients. Int Journal Urol 2019;26:737–43. https://doi.org/10.1111/iju.13989.Search in Google Scholar PubMed
3. Chennamsetty, A, Khourdaji, I, Burks, F, Killinger, KA. Contemporary diagnosis and management of Fournier’s gangrene. Ther Adv Urol 2015;7:203–15. https://doi.org/10.1177/1756287215584740.Search in Google Scholar PubMed PubMed Central
4. Atakan, IH, Kaplan, M, Kaya, E, Aktoz, T, Inci, O. A life-threatening infection: Fournier’s gangrene. Int Urol Nephrol 2002;34:387–92. https://doi.org/10.1023/a:1024427418743.10.1023/A:1024427418743Search in Google Scholar
5. Üreyen, O, Acar, A, Gökçelli, U, Atahan, MK, İlhan, E. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier’s gangrene: a multicenter study. Ulus Travma Acil Cerrahi Derg 2017;23:389–94. https://doi.org/10.5505/tjtes.2017.71509.Search in Google Scholar PubMed
6. Sadettin, E, Topcu, R, Tikici, D, Özden, S. Fournier gangrening mortality öngörmede skorlama sistemlerinin değerlendirilmesi. Turk J Clin Lab 2019;10:230–4.10.18663/tjcl.542072Search in Google Scholar
7. Martínez-Rodríguez, R, Ponce de León, J, Caparrós, J, Villavicencio, H. Fournier’s gangrene: a monographic urology center experience with twenty patients. Urol Int 2009;83:323–8. https://doi.org/10.1159/000241676.Search in Google Scholar PubMed
8. Jeong, HJ, Park, SC, Seo, IY, Rim, JS. Prognostic factors in Fournier gangrene. Int J Urol 2005;12:1041–4. https://doi.org/10.1111/j.1442-2042.2005.01204.x.Search in Google Scholar PubMed
9. Roghmann, F, von Bodman, C, Löppenberg, B, Hinkel, A, Palisaar, J, Noldus, J. Is there a need for the Fournier’s gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier’s gangrene. BJU Int 2012;110:1359–65. https://doi.org/10.1111/j.1464-410x.2012.11082.x.Search in Google Scholar
10. Demir, CY, Yuzkat, N, Ozsular, Y, Kocak, OF, Soyalp, C, Demirkiran, H. Fournier gangrene: association of mortality with the complete blood count parameters. Plast Reconstr Surg 2018;142:68e–75e. https://doi.org/10.1097/prs.0000000000004516.Search in Google Scholar
11. Doluoğlu, ÖG, Karagöz, MA, Kılınç, MF, Karakan, T, Yücetürk, CN, Sarıcı, H, et al.. Overview of different scoring systems in Fournier’s gangrene and assessment of prognostic factors. Turk J Urol 2016;42:190–6. https://doi.org/10.5152/tud.2016.14194.Search in Google Scholar PubMed PubMed Central
12. Ustyantseva, M, Khokhlova, O, Agadzhanyan, V. Innovative technologies in the evaluation of the neutrophil functional activity in sepsis. Sysmex J Int 2019;29:34–9.Search in Google Scholar
13. Buoro, S, Seghezzi, M, Vavassori, M, Dominoni, P, Esposito, SA, Manenti, B, et al.. Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment. Ann Transl Med 2016;4:418. https://doi.org/10.21037/atm.2016.10.73.Search in Google Scholar PubMed PubMed Central
14. Park, SH, Park, CJ, Lee, BR, Nam, KS, Kim, MJ, Han, MY, et al.. Sepsis affects most routine and cell population data (CPD) obtained using the sysmex XN-2000 blood cell analyzer: neutrophil-related CPD NE-SFL and NE-WY provide useful information for detecting sepsis. Int J Lab Hematol 2015;37:190–8. https://doi.org/10.1111/ijlh.12261.Search in Google Scholar PubMed
15. Urrechaga, E, Bóveda, O, Aguirre, U, García, S, Pulido, E. Neutrophil cell population data biomarkers for acute bacterial infection. J Pathol Infect Dis 2018;1:1–7. https://doi.org/10.33309/2639-8893.010106.Search in Google Scholar
16. Kaneda, M, Nagaoka, K, Yoshida, R, Iwasaki, Y, Niimi, H, Yamamoto, Y. Time-dependent changes in cell population data obtained using Sysmex XN-series hematology analyzer in bacterial infections. J Infect Chemother 2024. https://doi.org/10.1016/j.jiac.2024.03.008.Search in Google Scholar PubMed
17. Zhu, Y, Cao, X, Chen, Y, Zhang, K, Wang, Y, Yuan, K, et al.. Neutrophil cell population data: useful indicators for postsurgical bacterial infection. Int J Lab Hematol 2012;34:295–9. https://doi.org/10.1111/j.1751-553x.2011.01394.x.Search in Google Scholar PubMed
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- Review
- BDNF-altering cell death mechanisms of brain disorders: pyroptosis and/or ferroptosis? A systematic review
- Research Articles
- Evaluation of the implementation of the rational use of laboratory tests in the clinical chemistry laboratory
- Right vagotomy alters heart rate variability temporarily and increases total choline levels in rats
- Utilizing cell population data for diagnosis and intensive care unit requirement prediction in Fournier gangrene patients
- Evaluation of adropin indices and PCSK9 in non-diabetic men with severe obstructive sleep apnea
- The effect of curcumin on PI3K/Akt and AMPK pathways in insulin resistance induced by fructose
- Isoquercitrin attenuates neuroinflammation in LPS-stimulated BV2 microglia cells via p38MAPK/NF-κB pathway
- In vitro and in silico investigations of the pro-apoptotic activity of Opuntia ficus-indica cladode extracts against K562 cells
- Human estrogen receptor alpha (ERα) targeted cyclic peptides inhibit cell growth and induce apoptosis in MCF-7 cells
- Differential effects of choline on TLR2/4 mediated signaling through possible regulation of Toll-interacting protein in hepatocellular carcinoma cell lines
- Determination of molecular pathways and gene ontology of genes associated with Raynaud’s phenomenon
- Joint effects of PPARG-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation
- CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective
- Investigation of the effect of low-power, low-frequency ultrasound application on SARS-COV-2
Articles in the same Issue
- Frontmatter
- Review
- BDNF-altering cell death mechanisms of brain disorders: pyroptosis and/or ferroptosis? A systematic review
- Research Articles
- Evaluation of the implementation of the rational use of laboratory tests in the clinical chemistry laboratory
- Right vagotomy alters heart rate variability temporarily and increases total choline levels in rats
- Utilizing cell population data for diagnosis and intensive care unit requirement prediction in Fournier gangrene patients
- Evaluation of adropin indices and PCSK9 in non-diabetic men with severe obstructive sleep apnea
- The effect of curcumin on PI3K/Akt and AMPK pathways in insulin resistance induced by fructose
- Isoquercitrin attenuates neuroinflammation in LPS-stimulated BV2 microglia cells via p38MAPK/NF-κB pathway
- In vitro and in silico investigations of the pro-apoptotic activity of Opuntia ficus-indica cladode extracts against K562 cells
- Human estrogen receptor alpha (ERα) targeted cyclic peptides inhibit cell growth and induce apoptosis in MCF-7 cells
- Differential effects of choline on TLR2/4 mediated signaling through possible regulation of Toll-interacting protein in hepatocellular carcinoma cell lines
- Determination of molecular pathways and gene ontology of genes associated with Raynaud’s phenomenon
- Joint effects of PPARG-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation
- CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective
- Investigation of the effect of low-power, low-frequency ultrasound application on SARS-COV-2